Skip to main content
Erschienen in: Reviews in Endocrine and Metabolic Disorders 1/2017

01.09.2016

Gonadal dysfunction in chronic kidney disease

verfasst von: Biff F. Palmer, Deborah J. Clegg

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Sexual dysfunction is a common finding in both men and women with chronic kidney failure. Common disturbances include erectile dysfunction in men, menstrual abnormalities in women, and decreased libido and fertility in both sexes. These abnormalities are primarily organic in nature and are related to uremia as well as the other comorbid conditions that frequently occur in the chronic kidney failure patient. Fatigue and psycho social factors related to the presence of a chronic disease are also contributory factors. Disturbances in the hypothalamic-pituitary-gonadal axis can be detected prior to the need for dialysis but continue to worsen once dialytic therapy is initiated. Impaired gonadal function is prominent in uremic men while the disturbances in the hypothalamic-pituitary axis are more subtle. By contrast, central disturbances are more prominent in uremic women. Therapy is initially directed towards optimizing the delivery of dialysis, correcting anemia with recombinant erythropoietin, and controlling the degree of secondary hyperparathyroidism with vitamin D. For many practicing nephrologists sildenafil has become the first line therapy in the treatment of impotence. In the hypogonadal man whose only complaint is decreased libido, testosterone may be of benefit. Regular gynecologic follow up is required in uremic women to guard against potential complications of unopposed estrogen effect. Uremic women should be advised against pregnancy while on dialysis. Successful transplantation is the most effective means of restoring normal sexual function in both men and women with chronic kidney failure.
Literatur
1.
Zurück zum Zitat Procci WR, Goldstein DA, Adelstein J, Massry SG. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Intl. 1981;19:317–23.CrossRef Procci WR, Goldstein DA, Adelstein J, Massry SG. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Intl. 1981;19:317–23.CrossRef
2.
Zurück zum Zitat Toorians AWFT, Janssen E, Laan E, Gooren LJG, Giltay EJ, Oe PL, Donker AJM, Everaerd W. Chronic kidney failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephrol Dial Transplant. 1997;12:2654–63.CrossRefPubMed Toorians AWFT, Janssen E, Laan E, Gooren LJG, Giltay EJ, Oe PL, Donker AJM, Everaerd W. Chronic kidney failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephrol Dial Transplant. 1997;12:2654–63.CrossRefPubMed
3.
Zurück zum Zitat Rosas SE, Joffe M, Franklin E, Strom BL, Kotzker W, Brensinger C, Grossman E, Glasser D, Feldman HI. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int. 2001;59:2259–66.CrossRefPubMed Rosas SE, Joffe M, Franklin E, Strom BL, Kotzker W, Brensinger C, Grossman E, Glasser D, Feldman HI. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int. 2001;59:2259–66.CrossRefPubMed
4.
Zurück zum Zitat Turk S, Karalezli G, Tonbul HZ, Yildiz M, Altintepe L, Yildiz A, Yeksan M. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2001;16:1818–22.CrossRefPubMed Turk S, Karalezli G, Tonbul HZ, Yildiz M, Altintepe L, Yildiz A, Yeksan M. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2001;16:1818–22.CrossRefPubMed
5.
Zurück zum Zitat Navaneethan S, Vecchio M, Johnson D, et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis. 2010;56:670–85.CrossRefPubMed Navaneethan S, Vecchio M, Johnson D, et al. Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis. 2010;56:670–85.CrossRefPubMed
6.
Zurück zum Zitat Collaborative Depression and Sexual Dysfunction in Hemodialysis Working Group. Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study. Nephrol Dial Transplant. 2012;27:2479–88.CrossRef Collaborative Depression and Sexual Dysfunction in Hemodialysis Working Group. Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study. Nephrol Dial Transplant. 2012;27:2479–88.CrossRef
7.
Zurück zum Zitat Kaufman JM, Hatzichristou DG, Mulhall JP, Fitch WP, Goldstein I. Impotence and chronic kidney failure: a study of the hemodynamic pathophysiology. J Urol. 1994;151:612–8.PubMed Kaufman JM, Hatzichristou DG, Mulhall JP, Fitch WP, Goldstein I. Impotence and chronic kidney failure: a study of the hemodynamic pathophysiology. J Urol. 1994;151:612–8.PubMed
8.
Zurück zum Zitat Michal V, Kramar R, Pospichal J. External iliac "steal syndrome. J Cardiovasc Surg. 1978;19:355–7. Michal V, Kramar R, Pospichal J. External iliac "steal syndrome. J Cardiovasc Surg. 1978;19:355–7.
9.
Zurück zum Zitat Billips K. Erectile dysfunction as a marker for vascular disease. Curr Urol Rep. 2005;6:439–44.CrossRef Billips K. Erectile dysfunction as a marker for vascular disease. Curr Urol Rep. 2005;6:439–44.CrossRef
10.
Zurück zum Zitat Elesber A. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J. 2006;27:824–31.CrossRefPubMed Elesber A. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J. 2006;27:824–31.CrossRefPubMed
11.
Zurück zum Zitat Campese VM, Procci WR, Levitan D, Romoff MS, Goldstein DA, Massry SG. Autonomic nervous system dysfunction and impotence in uremia. Am J Nephrol. 1982;2:140–3.CrossRefPubMed Campese VM, Procci WR, Levitan D, Romoff MS, Goldstein DA, Massry SG. Autonomic nervous system dysfunction and impotence in uremia. Am J Nephrol. 1982;2:140–3.CrossRefPubMed
12.
Zurück zum Zitat Holdsworth SR, de Kretser DM, Atkins RC. A comparison of hemodialysis and transplantation in reversing the uremic disturbance of male reproductive function. Clin Nephrol. 1978;10:146–50.PubMed Holdsworth SR, de Kretser DM, Atkins RC. A comparison of hemodialysis and transplantation in reversing the uremic disturbance of male reproductive function. Clin Nephrol. 1978;10:146–50.PubMed
13.
Zurück zum Zitat Diemont WL, Vruggink PA, Meuleman EJ, Doesburg WH, Lemmens WA, Berden JH. Sexual dysfunction after kidney replacement therapy. Am J Kidney Dis. 2000;35:845–51.CrossRefPubMed Diemont WL, Vruggink PA, Meuleman EJ, Doesburg WH, Lemmens WA, Berden JH. Sexual dysfunction after kidney replacement therapy. Am J Kidney Dis. 2000;35:845–51.CrossRefPubMed
14.
Zurück zum Zitat Prem AR, Punekar SV, Kalpana M, Kelkar AR, Acharya VN. Male reproductive function in uraemia: efficacy of haemodialysis and kidney transplantation. Brit. J Urol. 1996;78:635–8.CrossRef Prem AR, Punekar SV, Kalpana M, Kelkar AR, Acharya VN. Male reproductive function in uraemia: efficacy of haemodialysis and kidney transplantation. Brit. J Urol. 1996;78:635–8.CrossRef
15.
Zurück zum Zitat Guvel S. Calcification of the epididymis and the tunica albuginea of the corpora cavernosa in patients on maintenance hemodialysis. J Androl. 2004;25:752–6.CrossRefPubMed Guvel S. Calcification of the epididymis and the tunica albuginea of the corpora cavernosa in patients on maintenance hemodialysis. J Androl. 2004;25:752–6.CrossRefPubMed
16.
Zurück zum Zitat Bellinghieri G. Ultrastructural changes of corpora cavernosa in men with erectile dysfunction and chronic renal failure. Semin Nephrol. 2004;24:488–91.CrossRefPubMed Bellinghieri G. Ultrastructural changes of corpora cavernosa in men with erectile dysfunction and chronic renal failure. Semin Nephrol. 2004;24:488–91.CrossRefPubMed
17.
Zurück zum Zitat Handelsman DJ. Hypothalamic-pituitary gonadal dysfunction in kidney failure, dialysis and kidney transplantation. Endocr Rev. 1985;6:151–82.CrossRefPubMed Handelsman DJ. Hypothalamic-pituitary gonadal dysfunction in kidney failure, dialysis and kidney transplantation. Endocr Rev. 1985;6:151–82.CrossRefPubMed
18.
Zurück zum Zitat Hauser R. Evidence of interaction between polychlorinated biphenyls and phthalates in relation to human sperm motility. Environ Health Perspect. 2005;113:425–30.CrossRefPubMedPubMedCentral Hauser R. Evidence of interaction between polychlorinated biphenyls and phthalates in relation to human sperm motility. Environ Health Perspect. 2005;113:425–30.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat De Vries CP, Gooren LJG, Oe PL. Haemodialysis and testicular function. Int J. Andrology. 1984;7:97–103. De Vries CP, Gooren LJG, Oe PL. Haemodialysis and testicular function. Int J. Andrology. 1984;7:97–103.
20.
Zurück zum Zitat Levitan D, Moser SA, Goldstein DA, Kletzky OA, Lobo RA, Massry SG. Disturbances in the hypothalamic-pituitary-gonadal axis in male patients with acute kidney failure. Am J Nephrol. 1984;4:99–106.CrossRefPubMed Levitan D, Moser SA, Goldstein DA, Kletzky OA, Lobo RA, Massry SG. Disturbances in the hypothalamic-pituitary-gonadal axis in male patients with acute kidney failure. Am J Nephrol. 1984;4:99–106.CrossRefPubMed
21.
Zurück zum Zitat Lim VS, Fang VS. Restoration of plasma testosterone levels in uremic men with clomiphene citrate. J Clin Endocrinol Metab. 1976;43:1370–7.CrossRefPubMed Lim VS, Fang VS. Restoration of plasma testosterone levels in uremic men with clomiphene citrate. J Clin Endocrinol Metab. 1976;43:1370–7.CrossRefPubMed
22.
Zurück zum Zitat Albaaj F. Prevalence of hypogonadism in male patients with renal failure. Postgrad Med. 2006;82:693–6.CrossRef Albaaj F. Prevalence of hypogonadism in male patients with renal failure. Postgrad Med. 2006;82:693–6.CrossRef
23.
Zurück zum Zitat Stewart-Bentley M, Gans D, Horton R. Regulation of gonadal function in uremia. Metabolism. 1974;23:1065–72.CrossRefPubMed Stewart-Bentley M, Gans D, Horton R. Regulation of gonadal function in uremia. Metabolism. 1974;23:1065–72.CrossRefPubMed
24.
Zurück zum Zitat Dunkel L, Raivio T, Laine J, Holmberg C. Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic kidney failure. Kidney Int. 1997;51:777–84.CrossRefPubMed Dunkel L, Raivio T, Laine J, Holmberg C. Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic kidney failure. Kidney Int. 1997;51:777–84.CrossRefPubMed
25.
Zurück zum Zitat Cardoso EM, Contreras LN, Tumilasci EG, Elbert A, Aguirre EC, Aquilano DR, Arregger AL. Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease. Nephrol Dial Transplant. 2011;26:677–83.CrossRefPubMed Cardoso EM, Contreras LN, Tumilasci EG, Elbert A, Aguirre EC, Aquilano DR, Arregger AL. Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease. Nephrol Dial Transplant. 2011;26:677–83.CrossRefPubMed
26.
Zurück zum Zitat LeRoith D, Danovitz G, Trestian S, Spitz IM. Dissociation of pituitary glycoprotein response to releasing hormones in chronic kidney failure. Acta Endocrinol. 1980;93:277–82.PubMed LeRoith D, Danovitz G, Trestian S, Spitz IM. Dissociation of pituitary glycoprotein response to releasing hormones in chronic kidney failure. Acta Endocrinol. 1980;93:277–82.PubMed
27.
Zurück zum Zitat Schaefer F, Veldhuis JD, Robertson WR, Dunger D. Schärer, the cooperative study group on pubertal development in chronic kidney failure: immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic kidney failure. Kidney Int. 1994;45:1465–76.CrossRefPubMed Schaefer F, Veldhuis JD, Robertson WR, Dunger D. Schärer, the cooperative study group on pubertal development in chronic kidney failure: immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic kidney failure. Kidney Int. 1994;45:1465–76.CrossRefPubMed
28.
Zurück zum Zitat Ayub W, Fletcher S. End stage kidney disease and erectile dysfunction. Is there any hope? Nephrol Dial Transplant. 2000;15:1525–8.CrossRefPubMed Ayub W, Fletcher S. End stage kidney disease and erectile dysfunction. Is there any hope? Nephrol Dial Transplant. 2000;15:1525–8.CrossRefPubMed
29.
Zurück zum Zitat Phocas I, Sarandakou A, Rizos D, Kapetanaki A. Serum α-immunoreactive inhibitin in males with kidney failure, under haemodialysis and after successful kidney transplantation. Andrologia. 1995;27:253–8.CrossRefPubMed Phocas I, Sarandakou A, Rizos D, Kapetanaki A. Serum α-immunoreactive inhibitin in males with kidney failure, under haemodialysis and after successful kidney transplantation. Andrologia. 1995;27:253–8.CrossRefPubMed
30.
Zurück zum Zitat Gomez F, de la Cueva R, Wauters J-P, Lemarchand-Beraud T. Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin. Amer. J Med. 1980;68:522–30.CrossRef Gomez F, de la Cueva R, Wauters J-P, Lemarchand-Beraud T. Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin. Amer. J Med. 1980;68:522–30.CrossRef
31.
Zurück zum Zitat Isaac R, Merceron RE, Caillens G, Raymond J-P, Ardaillou R. Effect of parathyroid hormone on plasma prolactin in man. J Clin Encrinol Metab. 1978;47:18–23.CrossRef Isaac R, Merceron RE, Caillens G, Raymond J-P, Ardaillou R. Effect of parathyroid hormone on plasma prolactin in man. J Clin Encrinol Metab. 1978;47:18–23.CrossRef
32.
Zurück zum Zitat Massry SG, Goldstein DA, Procci WR, Kletzky OA. Impotence in patients with uremia: a possible role for parathyroid hormone. Nephron. 1997;19:305–10.CrossRef Massry SG, Goldstein DA, Procci WR, Kletzky OA. Impotence in patients with uremia: a possible role for parathyroid hormone. Nephron. 1997;19:305–10.CrossRef
33.
Zurück zum Zitat Blumberg A, Wildbolz A, Descoeudres C, Hennes U, Dambacher MA, Fischer JA, Weidmann P. Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patients on maintenance hemodialysis. Clin Nephrol. 1980;13:208–14.PubMed Blumberg A, Wildbolz A, Descoeudres C, Hennes U, Dambacher MA, Fischer JA, Weidmann P. Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patients on maintenance hemodialysis. Clin Nephrol. 1980;13:208–14.PubMed
34.
Zurück zum Zitat Caticha O, Norato DYJ, Tambascia MA, Santana A, Stephanou A, Sarlis NJ. Total body zinc depletion and its relationship to the development of hyperprolactinemia in chronic kidney insufficiency. J Endocrinol Investig. 1996;19:441–8.CrossRef Caticha O, Norato DYJ, Tambascia MA, Santana A, Stephanou A, Sarlis NJ. Total body zinc depletion and its relationship to the development of hyperprolactinemia in chronic kidney insufficiency. J Endocrinol Investig. 1996;19:441–8.CrossRef
35.
Zurück zum Zitat Procci W. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Int. 1981;19:317–23.CrossRefPubMed Procci W. Sexual dysfunction in the male patient with uremia: a reappraisal. Kidney Int. 1981;19:317–23.CrossRefPubMed
36.
Zurück zum Zitat Steele TE, Wuerth D, Finkelstein S, Juergensen D, Juergensen P, Kliger AS, Finkelstein FO. Sexual experience of the chronic peritoneal dialysis patient. J Am Soc Nephrol. 1996;7:1165–8.PubMed Steele TE, Wuerth D, Finkelstein S, Juergensen D, Juergensen P, Kliger AS, Finkelstein FO. Sexual experience of the chronic peritoneal dialysis patient. J Am Soc Nephrol. 1996;7:1165–8.PubMed
37.
Zurück zum Zitat Finkelstein F. Therapy insight:sexual dysfunction in patients with chronic kidney disease. Nature Clin Practice Nephrol. 2007;3:200–7.CrossRef Finkelstein F. Therapy insight:sexual dysfunction in patients with chronic kidney disease. Nature Clin Practice Nephrol. 2007;3:200–7.CrossRef
38.
Zurück zum Zitat Toorians A. Chronic kidney failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephro. Dial Transplant. 1997;12:2654–63.CrossRef Toorians A. Chronic kidney failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephro. Dial Transplant. 1997;12:2654–63.CrossRef
39.
Zurück zum Zitat Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, Corradi L. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens. 2001;14:27–31.CrossRefPubMed Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, Corradi L. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens. 2001;14:27–31.CrossRefPubMed
40.
Zurück zum Zitat Bailie G. Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS. Nephrol Dial Transplant. 2007;22:1163–7.CrossRefPubMed Bailie G. Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: results from the DOPPS. Nephrol Dial Transplant. 2007;22:1163–7.CrossRefPubMed
41.
Zurück zum Zitat Palmer BF. Editorial review: management of sexual dysfunction: responsibility of the primary care physician or the specialist. Advances Kidney Replacement Therapy (Web-only editorial). 1999;6:E4. Palmer BF. Editorial review: management of sexual dysfunction: responsibility of the primary care physician or the specialist. Advances Kidney Replacement Therapy (Web-only editorial). 1999;6:E4.
42.
Zurück zum Zitat Kokot F, Wicek A, Schmidt-Gayk H, Marcinkowski W, Gilge U, Heidland A, Rudka R, Trembecki J. Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy. Artif Org. 1995;19:428–35.CrossRef Kokot F, Wicek A, Schmidt-Gayk H, Marcinkowski W, Gilge U, Heidland A, Rudka R, Trembecki J. Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy. Artif Org. 1995;19:428–35.CrossRef
43.
Zurück zum Zitat Schaefer F, van Kaick B, Veldhuis JD, Stein G, Schärer K, Robertson WR, Ritz E. Changes in the kinetics and biopotency of luteinizing hormone in hemodialyzed men during treatment with recombinant human erythropoietin. J Am Soc Nephrol. 1994;5:1208–15.PubMed Schaefer F, van Kaick B, Veldhuis JD, Stein G, Schärer K, Robertson WR, Ritz E. Changes in the kinetics and biopotency of luteinizing hormone in hemodialyzed men during treatment with recombinant human erythropoietin. J Am Soc Nephrol. 1994;5:1208–15.PubMed
44.
Zurück zum Zitat Schaefer RM, Kokot F, Wernze H, Geiger H, Heidland A. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. Clin Nephrol. 1989;31:1–5.PubMed Schaefer RM, Kokot F, Wernze H, Geiger H, Heidland A. Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. Clin Nephrol. 1989;31:1–5.PubMed
45.
Zurück zum Zitat O'Sullivan DA, McCarthy JT, Kumar R, Williams AW. Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: a pilot study. Mayo Clin Proc. 1998;73:1035–45.CrossRefPubMed O'Sullivan DA, McCarthy JT, Kumar R, Williams AW. Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: a pilot study. Mayo Clin Proc. 1998;73:1035–45.CrossRefPubMed
46.
Zurück zum Zitat McPhatter LL, Lockridge Jr RS, Albert J, Anderson H, Craft V, Jennings FM, Spencer M, Swafford A, Barger T, Coffey L. Nightly home hemodialysis: improvement in nutrition and quality of life. Adv Ren Replace Ther. 1999;6:358–65.PubMed McPhatter LL, Lockridge Jr RS, Albert J, Anderson H, Craft V, Jennings FM, Spencer M, Swafford A, Barger T, Coffey L. Nightly home hemodialysis: improvement in nutrition and quality of life. Adv Ren Replace Ther. 1999;6:358–65.PubMed
47.
48.
Zurück zum Zitat Rendell MS, Rajfer J, Wicker PA, Smith MD. For the sildenafil diabetes study group: sildenafil for treatment of erectile dysfunction in men with diabetes. A randomized controlled trial. J Am Med Assoc. 1999;281:421–6.CrossRef Rendell MS, Rajfer J, Wicker PA, Smith MD. For the sildenafil diabetes study group: sildenafil for treatment of erectile dysfunction in men with diabetes. A randomized controlled trial. J Am Med Assoc. 1999;281:421–6.CrossRef
49.
Zurück zum Zitat Chen J, Mabjeesh NJ, Greenstein A, Nadu A, Matzkin H. Clinical efficacy of sildenafil in patients on chronic dialysis. J Urol. 2001;165:819–21.CrossRefPubMed Chen J, Mabjeesh NJ, Greenstein A, Nadu A, Matzkin H. Clinical efficacy of sildenafil in patients on chronic dialysis. J Urol. 2001;165:819–21.CrossRefPubMed
50.
Zurück zum Zitat Rosas SE, Wasserstein A, Kobrin S, Feldman HI. Preliminary observations of sildenafil treatment for erectile dysfunction in dialysis patients. Am J Kidney Dis. 2001;37:134–7.CrossRefPubMed Rosas SE, Wasserstein A, Kobrin S, Feldman HI. Preliminary observations of sildenafil treatment for erectile dysfunction in dialysis patients. Am J Kidney Dis. 2001;37:134–7.CrossRefPubMed
51.
Zurück zum Zitat Sam R, Patel P. Sildenafil in dialysis patients. Int J Artif Organs. 2006;29:264–8.PubMed Sam R, Patel P. Sildenafil in dialysis patients. Int J Artif Organs. 2006;29:264–8.PubMed
52.
Zurück zum Zitat Solak Y, Atalay H, Kan S, Kaynar M, Bodur S, Yeksan M, Turk S. Effects of sildenafil and vardenafil treatments on sleep quality and depression in hemodialysis patients with erectile dysfunction. Int J Impot Res. 2011;23:27–31.CrossRefPubMed Solak Y, Atalay H, Kan S, Kaynar M, Bodur S, Yeksan M, Turk S. Effects of sildenafil and vardenafil treatments on sleep quality and depression in hemodialysis patients with erectile dysfunction. Int J Impot Res. 2011;23:27–31.CrossRefPubMed
53.
Zurück zum Zitat Dachille G. Sexual dysfunction in patients under diaytic treatment. Minerva Urol Nefrol. 2006;58:195–200.PubMed Dachille G. Sexual dysfunction in patients under diaytic treatment. Minerva Urol Nefrol. 2006;58:195–200.PubMed
54.
Zurück zum Zitat Sharma R. Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: a randomized, double blind, placebo-controlled, crossover trial. Am J Kidney Dis. 2006;48:128–33.CrossRefPubMed Sharma R. Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: a randomized, double blind, placebo-controlled, crossover trial. Am J Kidney Dis. 2006;48:128–33.CrossRefPubMed
55.
Zurück zum Zitat Ketteler M, Ritz E. Kidney failure: a state of nitric oxide deficiency? Kidney Int. 2000;58:1356–7.CrossRefPubMed Ketteler M, Ritz E. Kidney failure: a state of nitric oxide deficiency? Kidney Int. 2000;58:1356–7.CrossRefPubMed
57.
Zurück zum Zitat Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 1989;320:1025–30.CrossRefPubMed Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 1989;320:1025–30.CrossRefPubMed
58.
Zurück zum Zitat Mills TM, Wiedmeier VT, Stopper VS. Androgen maintenance of erectile function in the rat penis. Biol Reprod. 1992;46:342–8.CrossRefPubMed Mills TM, Wiedmeier VT, Stopper VS. Androgen maintenance of erectile function in the rat penis. Biol Reprod. 1992;46:342–8.CrossRefPubMed
59.
Zurück zum Zitat Bellinghieri G, Santoro D, Lo Forti B, Mallamace A, De Santo RM, Savica V. Erectile dysfunction in uremic dialysis patients: diagnostic evaluation in the sildenafil era. Am J Kidney Dis. 2001;38(4 Suppl 1):S115–7.CrossRefPubMed Bellinghieri G, Santoro D, Lo Forti B, Mallamace A, De Santo RM, Savica V. Erectile dysfunction in uremic dialysis patients: diagnostic evaluation in the sildenafil era. Am J Kidney Dis. 2001;38(4 Suppl 1):S115–7.CrossRefPubMed
60.
Zurück zum Zitat Mohamed EA, MacDowall P, Coward RA. Timing of sildenafil therapy in dialysis patients lessons following an episode of hypotension. Nephrol Dial Transplant. 2000;15:926–7.CrossRefPubMed Mohamed EA, MacDowall P, Coward RA. Timing of sildenafil therapy in dialysis patients lessons following an episode of hypotension. Nephrol Dial Transplant. 2000;15:926–7.CrossRefPubMed
61.
Zurück zum Zitat Mahajan SK, Abbasi AA, Prasad AS, Rabbani P, Briggs WA, McDonald FD. Effect of oral zinc therapy on gonadal function in hemodialysis patients. Ann Intern Med. 1982;97:357–61.CrossRefPubMed Mahajan SK, Abbasi AA, Prasad AS, Rabbani P, Briggs WA, McDonald FD. Effect of oral zinc therapy on gonadal function in hemodialysis patients. Ann Intern Med. 1982;97:357–61.CrossRefPubMed
62.
Zurück zum Zitat Vecchio M, Navaneethan S, Johnson D, Lucisano G, Graziano G, Querques M, Saglimbene V, Ruospo M, Bonifati C, Jannini EA, Strippoli G. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clin J Am Soc Nephrol. 2010;5:985–95.CrossRefPubMedPubMedCentral Vecchio M, Navaneethan S, Johnson D, Lucisano G, Graziano G, Querques M, Saglimbene V, Ruospo M, Bonifati C, Jannini EA, Strippoli G. Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trials. Clin J Am Soc Nephrol. 2010;5:985–95.CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Lawrence IG, Price DE, Howlett TA, Harris KPG, Feehally J, Walls J. Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kid Dis. 1998;31:313–9.CrossRefPubMed Lawrence IG, Price DE, Howlett TA, Harris KPG, Feehally J, Walls J. Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kid Dis. 1998;31:313–9.CrossRefPubMed
64.
Zurück zum Zitat Pertuz W, Castaneda D, Rincon O, Lozano E. Sexual dysfunction in patients with chronic renal disease: does it improve with renal transplantation? Transplant Proc. 2014;46:3021–6.CrossRefPubMed Pertuz W, Castaneda D, Rincon O, Lozano E. Sexual dysfunction in patients with chronic renal disease: does it improve with renal transplantation? Transplant Proc. 2014;46:3021–6.CrossRefPubMed
65.
Zurück zum Zitat Barton CH, Mirahmadi MK, Vaziri ND. Effects of long term testosterone administration on pituitary testicular axis in end stage kidney failure. Nephron. 1982;31:61–4.CrossRefPubMed Barton CH, Mirahmadi MK, Vaziri ND. Effects of long term testosterone administration on pituitary testicular axis in end stage kidney failure. Nephron. 1982;31:61–4.CrossRefPubMed
66.
Zurück zum Zitat van Coevorden A, Stolear JC, Dhaene M, van Herweghem JL, Mockel J. Effect of chronic oral testosterone undecanoate administration on the pituitary testicular axes of hemodialyzed male patients. Clin Nephrol. 1986;26:48–54.PubMed van Coevorden A, Stolear JC, Dhaene M, van Herweghem JL, Mockel J. Effect of chronic oral testosterone undecanoate administration on the pituitary testicular axes of hemodialyzed male patients. Clin Nephrol. 1986;26:48–54.PubMed
67.
Zurück zum Zitat Stein M. Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Ds. 1996;28:515–22.CrossRef Stein M. Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Ds. 1996;28:515–22.CrossRef
68.
Zurück zum Zitat Stehman-Breen C. Racial differences in bone mineral density and bone loss among end-stage renal disease patients. Am J Kidney Dis. 1999;33:941–6.CrossRefPubMed Stehman-Breen C. Racial differences in bone mineral density and bone loss among end-stage renal disease patients. Am J Kidney Dis. 1999;33:941–6.CrossRefPubMed
69.
Zurück zum Zitat Palmer B. Outcomes associated with hypogonadism in men with chronic kidney disease. Adv Chronic Kidney Disease. 2004;11:342–7.CrossRef Palmer B. Outcomes associated with hypogonadism in men with chronic kidney disease. Adv Chronic Kidney Disease. 2004;11:342–7.CrossRef
70.
Zurück zum Zitat Johansen K. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. J Am Med Assoc. 1999;281:1275–81.CrossRef Johansen K. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. J Am Med Assoc. 1999;281:1275–81.CrossRef
71.
Zurück zum Zitat Singh A. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men. J Clin Endocrinol Metab. 2001;86:2437–45.PubMed Singh A. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men. J Clin Endocrinol Metab. 2001;86:2437–45.PubMed
72.
Zurück zum Zitat Hendler E. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. N Engl J Med. 1974;291:1046–51.CrossRefPubMed Hendler E. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. N Engl J Med. 1974;291:1046–51.CrossRefPubMed
73.
Zurück zum Zitat Neff MA. Comparison of androgens for anemia in patients on hemodialysis. N Engl J Med. 1981;304:871–5.CrossRefPubMed Neff MA. Comparison of androgens for anemia in patients on hemodialysis. N Engl J Med. 1981;304:871–5.CrossRefPubMed
74.
Zurück zum Zitat Johnson C. Use of androgens in patients with renal failure. Semin Dialysis. 2000;13:36–9.CrossRef Johnson C. Use of androgens in patients with renal failure. Semin Dialysis. 2000;13:36–9.CrossRef
75.
Zurück zum Zitat Teruel J. Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study. Nephron. 1995;70:282–6.CrossRefPubMed Teruel J. Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study. Nephron. 1995;70:282–6.CrossRefPubMed
76.
Zurück zum Zitat Gaughan WA. Six month study of low dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Am J Kidney Dis. 1997;30:495–500.CrossRefPubMed Gaughan WA. Six month study of low dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Am J Kidney Dis. 1997;30:495–500.CrossRefPubMed
77.
Zurück zum Zitat Brockenbrough A. Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic kidney disease. Am J Kidney Dis. 2006;47:251–62.CrossRefPubMed Brockenbrough A. Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic kidney disease. Am J Kidney Dis. 2006;47:251–62.CrossRefPubMed
78.
Zurück zum Zitat Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:3007–19.CrossRefPubMedPubMedCentral Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96:3007–19.CrossRefPubMedPubMedCentral
79.
Zurück zum Zitat Haring R, Nauck M, Völzke H, Endlich K, Lendeckel U, Friedrich N, Dörr M, Rettig R, Kroemer HK, Wallaschofski H. Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy. Am J Nephrol. 2011;33:209–17.CrossRefPubMed Haring R, Nauck M, Völzke H, Endlich K, Lendeckel U, Friedrich N, Dörr M, Rettig R, Kroemer HK, Wallaschofski H. Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy. Am J Nephrol. 2011;33:209–17.CrossRefPubMed
80.
Zurück zum Zitat Bello A, Stenvinkel P, Lin M, Hemmelgarn B, Thadhani R, Klarenbach S, Chan C, Zimmerman D, Cembrowski G, Strippoli G, Carrero J, Tonelli M. Serum testosterone levels and clinical outcomes in male hemodialysis patients. Am J Kidney Dis. 2014;63:268–75.CrossRefPubMed Bello A, Stenvinkel P, Lin M, Hemmelgarn B, Thadhani R, Klarenbach S, Chan C, Zimmerman D, Cembrowski G, Strippoli G, Carrero J, Tonelli M. Serum testosterone levels and clinical outcomes in male hemodialysis patients. Am J Kidney Dis. 2014;63:268–75.CrossRefPubMed
81.
Zurück zum Zitat Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV Jr, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis 2014;64:367–374 Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV Jr, Shoskes DA. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis 2014;64:367–374
82.
Zurück zum Zitat Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T, Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:1617–25.CrossRefPubMed Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T, Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:1617–25.CrossRefPubMed
83.
Zurück zum Zitat Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M. Gynecologic and reproductive issues in women on dialysis. Am J Kid Dis. 1997;29:685–90.CrossRefPubMed Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M. Gynecologic and reproductive issues in women on dialysis. Am J Kid Dis. 1997;29:685–90.CrossRefPubMed
84.
Zurück zum Zitat Ginsburg ES, Owen Jr WF. Reproductive endocrinology and pregnancy in women on hemodialysis. Sem Dial. 1993;6:105–16.CrossRef Ginsburg ES, Owen Jr WF. Reproductive endocrinology and pregnancy in women on hemodialysis. Sem Dial. 1993;6:105–16.CrossRef
85.
Zurück zum Zitat Peng Y. Sexual dysfunction in female hemodialysis patients: a multicenter study. Kidney Int. 2005;68:760–5.CrossRefPubMed Peng Y. Sexual dysfunction in female hemodialysis patients: a multicenter study. Kidney Int. 2005;68:760–5.CrossRefPubMed
86.
Zurück zum Zitat Barua M, Hladunewich M, Keunen J, Pierratos A, McFarlane P, Sood M, Chan C. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol. 2008;3:392–6.CrossRefPubMedPubMedCentral Barua M, Hladunewich M, Keunen J, Pierratos A, McFarlane P, Sood M, Chan C. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol. 2008;3:392–6.CrossRefPubMedPubMedCentral
87.
Zurück zum Zitat Hou S. Pregnancy in chronic kidney insufficiency and end-stage kidney disease. Am J Kidney Ds. 1999;33:235–52.CrossRef Hou S. Pregnancy in chronic kidney insufficiency and end-stage kidney disease. Am J Kidney Ds. 1999;33:235–52.CrossRef
88.
Zurück zum Zitat Lim VS, Henriquez C, Sievertsen G, Frohman LA. Ovarian function in chronic kidney failure: evidence suggesting hypothalamic anovulation. Ann Intern Med. 1980;93:21–7.CrossRefPubMed Lim VS, Henriquez C, Sievertsen G, Frohman LA. Ovarian function in chronic kidney failure: evidence suggesting hypothalamic anovulation. Ann Intern Med. 1980;93:21–7.CrossRefPubMed
89.
Zurück zum Zitat Zingraff J, Jungers P, Pélissier C, Nahoul K, Feinstein MC, Scholler R. Pituitary and ovarian dysfunctions in women on haemodialysis. Nephron. 1982;30:149–53.CrossRefPubMed Zingraff J, Jungers P, Pélissier C, Nahoul K, Feinstein MC, Scholler R. Pituitary and ovarian dysfunctions in women on haemodialysis. Nephron. 1982;30:149–53.CrossRefPubMed
90.
Zurück zum Zitat Mor M, Sevick M, Shields A, Green J, Palevsky P, Arnold R, Fine M, Weisbord S. Sexual function, activity, and satisfaction among women receiving maintenance hemodialysis. Clin J Am Soc Nephrol. 2014;9:128–34.CrossRefPubMed Mor M, Sevick M, Shields A, Green J, Palevsky P, Arnold R, Fine M, Weisbord S. Sexual function, activity, and satisfaction among women receiving maintenance hemodialysis. Clin J Am Soc Nephrol. 2014;9:128–34.CrossRefPubMed
91.
Zurück zum Zitat Strippoli G. For the collaborative depression and sexual dysfunction (CDS) in hemodialysis working group. Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol. 2012;7:974–81.CrossRefPubMedPubMedCentral Strippoli G. For the collaborative depression and sexual dysfunction (CDS) in hemodialysis working group. Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol. 2012;7:974–81.CrossRefPubMedPubMedCentral
92.
Zurück zum Zitat Simon J. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90:5226–33.CrossRefPubMed Simon J. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005;90:5226–33.CrossRefPubMed
93.
Zurück zum Zitat Weisinger JR, Gonzalez L, Alvarez H, Hernandez E, Carlini RG, Capriles F, Cervino M, Martinis R, Paz Martinez V, Bellorin Font E. Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women. Kidney Int. 2000;58:331–5.CrossRefPubMed Weisinger JR, Gonzalez L, Alvarez H, Hernandez E, Carlini RG, Capriles F, Cervino M, Martinis R, Paz Martinez V, Bellorin Font E. Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women. Kidney Int. 2000;58:331–5.CrossRefPubMed
94.
Zurück zum Zitat Cochrane R, Regan L. Undetected gynaecological disorders in women with kidney disease. Hum Reprod. 1997;12:667–70.CrossRefPubMed Cochrane R, Regan L. Undetected gynaecological disorders in women with kidney disease. Hum Reprod. 1997;12:667–70.CrossRefPubMed
95.
Zurück zum Zitat Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M. Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis. 1997;29:685–90.CrossRefPubMed Holley JL, Schmidt RJ, Bender FH, Dumler F, Schiff M. Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis. 1997;29:685–90.CrossRefPubMed
96.
Zurück zum Zitat Holley JL, Schmidt RJ. Hormone replacement therapy in postmenopausal women with end-stage kidney disease: a review of the issues. Semin Dial. 2001;14:146–9.CrossRefPubMed Holley JL, Schmidt RJ. Hormone replacement therapy in postmenopausal women with end-stage kidney disease: a review of the issues. Semin Dial. 2001;14:146–9.CrossRefPubMed
Metadaten
Titel
Gonadal dysfunction in chronic kidney disease
verfasst von
Biff F. Palmer
Deborah J. Clegg
Publikationsdatum
01.09.2016
Verlag
Springer US
Erschienen in
Reviews in Endocrine and Metabolic Disorders / Ausgabe 1/2017
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-016-9385-9

Weitere Artikel der Ausgabe 1/2017

Reviews in Endocrine and Metabolic Disorders 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.